ABBV

AbbVie
ABBV

Latest price

-

Financial Snapshot

gainify

Market Data

Market Cap
$377.52B
EV
$440.02B
Shares Outstanding
1.77B
Beta
0.60

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$211.73
P/E 2025E
17.42x
P/Revenue 2025E
6.36x

About AbbVie Inc.

gainify
ABBV

AbbVie Inc.

ABBV

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disea...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Michael, Robert

Employees

55,000

IPO Date

2013-01-02

Headquarters

1 North Waukegan Road, North Chicago, Illinois, 60064-6400, United States

© Copyright 2024, All Rights Reserved